Paper230581
Establishment of anti-TNP antibody-producing human lymphoid lines by preselection for hapten binding followed by EBV transformation.
Kozbor D and 4 others. Scand J Immunol, 1979. Cited by 51 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Download JSON
Cite this record
ConductScience Library. Establishment of anti-TNP antibody-producing human lymphoid lines by preselection for hapten binding followed by EBV transformation. Papers, record 230581. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/230581
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Establishment of anti-TNP antibody-producing human lymphoid lines by preselection for hapten binding followed by EBV transformation.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibody Formation | Major topic |
| B-Lymphocytes | Major topic |
| Cell Transformation, Viral | Major topic |
| Haptens | Major topic |
| Herpesvirus 4, Human | Major topic |
| Nitrobenzenes | Major topic |
| Trinitrobenzenes | Major topic |
| Antibodies | |
| Antibody Specificity | |
| Antigens, Viral | |
| Binding Sites, Antibody | |
| Cell Line | |
| Cross Reactions | |
| Erythrocytes | |
| Humans | |
| Immunoglobulins | |
| Rosette Formation | |
| Viral Plaque Assay |
Source PubMed
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 51 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 34,287,229 | Identification of Human SARS-CoV-2 Monoclonal Antibodies from Convalescent Patients Using EBV Immortalization. | Antibodies (Basel) | 2021 | https://conductscience.org/library/papers/34287229 | PubMed |
| 7,272,192 | In vitro production of human antibody to a tumour-associated foetal antigen. | Br J Cancer | 1981 | https://conductscience.org/library/papers/7272192 | PubMed |
| 6,325,331 | Anti-immunoglobulin inhibits DNA synthesis in Epstein-Barr virus-transformed lymphoblastoid cell lines. | Immunology | 1984 | https://conductscience.org/library/papers/6325331 | PubMed |
| 6,316,357 | Construction and testing of mouse--human heteromyelomas for human monoclonal antibody production. | Proc Natl Acad Sci U S A | 1983 | https://conductscience.org/library/papers/6316357 | PubMed |
| 6,309,856 | Epstein-Barr virus (EBV), lymphocytes and transformation. | J Cancer Res Clin Oncol | 1983 | https://conductscience.org/library/papers/6309856 | PubMed |
| 6,308,627 | Efficient generation in vitro, from human peripheral blood cells, of monoclonal Epstein-Barr virus transformants producing specific antibody to a variety of antigens without prior deliberate immunization. | Proc Natl Acad Sci U S A | 1983 | https://conductscience.org/library/papers/6308627 | PubMed |
| 6,292,911 | Human hybridomas constructed with antigen-specific Epstein-Barr virus-transformed cell lines. | Proc Natl Acad Sci U S A | 1982 | https://conductscience.org/library/papers/6292911 | PubMed |
| 6,172,364 | Hybridomas: a new dimension in biological analyses. | In Vitro | 1981 | https://conductscience.org/library/papers/6172364 | PubMed |
| 6,087,121 | Human monoclonal antibodies. | Mol Cell Biochem | 1984 | https://conductscience.org/library/papers/6087121 | PubMed |
| 3,094,942 | Human monoclonal antibody. Construction of stable clones reactive with human breast cancer. | Cancer Immunol Immunother | 1986 | https://conductscience.org/library/papers/3094942 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/230581
GET https://conductscience.org/api/papers/v1/230581/authors